Cytiva, SH30535.03, HyClone™ SFM4MAb media

HyClone SFM4MAb powdered medium without L-glutamine, 10 L
Increase process yields for manufacturing of human and humanized recombinant antibodies.
• Designed for high cell yield and antibody production
• Complexed lipids for enhanced stability
• Allow for direct or sequential adaptation
• Optimized for protein A, protein G, and other purification matrices
• Manufactured in cGMP (21 CFR 820) compliant and ISO9001 certified facilities
SFM4MAb is a low protein formulation and is optimized for downstream purification using protein A, protein G, and other matrices to facilitate product recovery. The medium is formulated using our proprietary lipid and phospholipid complexing process for enhanced stability and growth promotion of various cell types. SFM4MAb is available in liquid and powder formats in user-friendly packaging.
HyClone SFM4MAb medium is developed to increase the process yields for the industrial manufacture of recombinant antibodies and antibody fragments for therapeutic use. SFM4MAb has been optimized in a variety of engineered hybridoma and recombinant myeloma cell lines.